Cargando…
Antiplasmodial Activity Assay of 3-Chloro-4-(4-chlorophenoxy) Aniline Combinations with Artesunate or Chloroquine In Vitro and in a Mouse Model
Malaria is the eighth highest contributor to global disease burden with 212 million cases and 429,000 deaths reported in 2015. There is an urgent need to develop multiple target drug to curb growing resistance by Plasmodia due to use of single target drugs and lack of vaccines. Based on a previous s...
Autores principales: | Wekesa Sifuna, Martin, Wambui, Milka, Kang'ethe Nganga, Joseph, Wainaina Kariuki, Daniel, Kimani, Francis Thuo, Muregi, Francis Wamakima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855074/ https://www.ncbi.nlm.nih.gov/pubmed/31781619 http://dx.doi.org/10.1155/2019/5153482 |
Ejemplares similares
-
Antimalarial activity assay of artesunate-3-chloro-4(4-chlorophenoxy) aniline in vitro and in mice models
por: Waithera, Milka Wambui, et al.
Publicado: (2023) -
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin
por: Njokah, Muturi J., et al.
Publicado: (2016) -
Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model
por: Gimode, Winnie R, et al.
Publicado: (2015) -
3-Chloro-4-(4-chlorophenoxy)-N-[(Z)-(5-nitrothiophen-2-yl)methylidene]aniline
por: Özdemir Tarı, Gonca, et al.
Publicado: (2012) -
2-(4-Chlorophenoxy)-N′-[2-(4-chlorophenoxy)acetyl]acetohydrazide monohydrate
por: Chen, Ting, et al.
Publicado: (2010)